サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1429348

バイオテクノロジーサービスの世界市場レポート 2024年

Biotechnology Services Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオテクノロジーサービスの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

バイオテクノロジーサービスの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.1%の年間複合成長率（CAGR）で1,631億2,000万米ドルに成長すると予想されます。 バイオテクノロジーサービスの予測成長は、技術の進歩、農業ベースのサービスの需要の増加、合成生物学の台頭によって促進されます。主要動向には、戦略的コラボレーション、クラウドベースのデータ管理、医薬品調査における高度なシーケンシングとAI、臨床試験におけるデジタル化、診断における自動化、医薬品、食品、化学薬品、再生可能エネルギーのソリューションのための合成生物学への投資が含まれます。

B型肝炎、糖尿病、がんなどの病気の罹患率の増加により、バイオテクノロジーの分野における広範な調査が促進されています。この学際的な分野では、生物学と化学のツールを利用して細菌やウイルスの遺伝物質を精査し、病気の原因物質と効果的に闘います。特に、幹細胞治療、モノクローナル抗体治療、ゲノム配列決定の進歩により、重要な医療応用への道が開かれており、腫瘍学の調査は依然としてバイオ医薬品企業の基礎となっています。 2021年のインド経済調査によると、インドのバイオテクノロジー部門は2025年までに評価額 1,500億米ドルに達すると予想されています。その結果、病気の蔓延の急増と研究開発が成長を促進するのに役立つと予想されます。

慢性疾患の治療に対応する臨床ソリューションに対する需要の高まりは、バイオテクノロジーサービス市場の拡大の重要な推進力となるでしょう。慢性疾患には、通常3か月以上の長期間にわたって持続する持続的な病状が含まれます。 バイオテクノロジーサービスは、高度な治療法、精密医療、個々の患者に合わせた標的治療など、慢性疾患を管理するための革新的な臨床ソリューションを提供する上で極めて重要な役割を果たします。これらの進歩により、慢性疾患の管理と結果が大幅に向上します。たとえば、2022年9月の世界保健機関（WHO）によると、世界の死亡者数の74%は慢性疾患によるもので、年間死亡者数は4,100万人に上ります。これには、心血管疾患による死亡が1,790万人、がんによる死亡が930万人、慢性呼吸器疾患による死亡が410万人、糖尿病による死亡が200万人含まれています。したがって、慢性疾患の治療に合わせた臨床ソリューションに対する需要の高まりが、バイオテクノロジーサービス市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のバイオテクノロジーサービス市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のバイオテクノロジーサービスの市場規模実績と成長、2018～2023年
  • 世界のバイオテクノロジーサービス市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界のバイオテクノロジーサービス市場、サービス別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 予防と疾病管理
  • 市民参加活動
  • 健康教育と研究
  • 食品バイオテクノロジーサービス
  • ドナー募集
  • 組織採取
  • 細胞の処理と分離
  • 研究開発
  • 世界のバイオテクノロジーサービス市場、業界別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 臨床研究機関（CRO）
  • 受託製造業者組織（CMO）
  • 研究受託製造サービス（CRMS）
  • 世界のバイオテクノロジーサービス市場、応用分野別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 医薬品
  • バイオテクノロジー
  • アカデミック
  • 臨床試験
  • 医療分野

第7章 地域と国の分析

  • 世界のバイオテクノロジーサービス市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界のバイオテクノロジーサービス市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • バイオテクノロジーサービス市場の競合情勢
  • バイオテクノロジーサービス市場の企業プロファイル
    • Parexel International Corporation
    • Thermo Fisher Scientific
    • Laboratory Corporation of America Holdings
    • IQVIA
    • ICON plc

第31章 その他の大手と革新的な企業

  • Charles River Laboratories
  • Syneos Health
  • Sartorius AG
  • Precision for Medicine Inc.
  • Novartis
  • Eppendorf Asia Pacific Sdn. Bhd.
  • Emmessar Biotech &Nutrition Ltd
  • Vcanbio Cell &Gene Engineering Corp., Ltd
  • Ke Rui Gene
  • Absea Biotechnology Ltd
  • CStone Pharm-B
  • Daiichi Sankyo
  • bitBiome
  • Taisho Pharmaceutical
  • AGC Biologics

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r14360

Biotechnology services involve the modification of living microorganisms to produce customized biotechnology products for medical, pharmaceutical, and scientific laboratories on a contract or custom basis. These services contribute to the development of breakthrough products and technologies aimed at addressing diseases, environmental concerns, hunger, energy efficiency, and cleaner industrial processes.

Key types of biotechnology services include prevention and disease control, public engagement activities, health education and research, food biotechnology services, donor recruitment, tissue collection, cell processing and isolation, and research and development. Food biotechnology services cover various technologies applied in crops, livestock, forestry, fisheries, aquaculture, and agro-industry. These services are utilized for genetic improvement, conservation of genetic resources, disease diagnosis, vaccine development, and fermented food production. Applications of biotechnology services span the pharmaceutical, biotechnological, academic, clinical trial, and healthcare sectors, with usage by Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), and Contract Research and Manufacturing Services (CRAMS).

The biotechnology services market research report is one of a series of new reports from The Business Research Company that provides biotechnology services market statistics, including biotechnology services industry global market size, regional shares, competitors with a biotechnology services market share, detailed biotechnology services market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology services industry. This biotechnology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotechnology services market size has grown strongly in recent years. It will grow from $126.58 billion in 2023 to $133.74 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The historical growth in biotechnology services can be attributed to robust economic growth in emerging markets, heightened collaborations with other research institutes and companies, and an increased demand for food.

The biotechnology services market size is expected to see strong growth in the next few years. It will grow to $163.12 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. Forecasted growth in biotechnology services is fueled by technological advancements, increased demand for agriculture-based services, and the rise of synthetic biology. Key trends include strategic collaborations, cloud-based data management, advanced sequencing and AI in drug research, digitalization in clinical trials, automation in diagnostics, and investments in synthetic biology for solutions in medicine, food supplies, chemicals, and renewable energy.

The increasing prevalence of diseases such as hepatitis B, diabetes, and cancer is fueling extensive research within the realm of biotechnology. This interdisciplinary field utilizes tools from biology and chemistry to scrutinize the genetic material of bacteria and viruses, effectively combating disease-causing agents. Notably, oncology research remains a cornerstone for biopharmaceutical companies, with advancements in stem cell therapy, monoclonal antibody treatments, and genome sequencing paving the way for significant medical applications. As per the Indian Economic Survey 2021, the Indian biotechnology sector is anticipated to burgeon to a valuation of US$ 150 billion by 2025. Consequently, the surge in disease prevalence and substantial investments in research and development are expected to be instrumental in propelling the growth of the biotechnology services market.

The escalating demand for clinical solutions catering to chronic disease treatments is set to be a significant driver for the expansion of the biotechnology services market. Chronic diseases encompass enduring medical conditions persisting for an extended duration, typically three months or more. Biotechnology services play a pivotal role in offering innovative clinical solutions for managing chronic diseases, including advanced therapies, precision medicine, and targeted treatments personalized to individual patients. These advancements significantly enhance the management and outcomes of chronic ailments. For instance, as per the World Health Organization (WHO) in September 2022, chronic diseases account for 74% of global deaths, amounting to 41 million fatalities annually. This includes 17.9 million deaths attributed to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. Hence, the mounting demand for clinical solutions tailored to chronic disease treatment is a driving force behind the growth of the biotechnology services market.

Collaborations and partnerships between industry players are becoming increasingly prevalent in the biotech services sector. In January 2021, Novartis, a Swiss pharmaceutical company, entered into a collaboration with Alnylam, a US-based biopharmaceutical company. This partnership aimed to explore Alnylam's siRNA technology and develop targeted therapies to restore liver function. Under an exclusive three-year research collaboration, Alnylam would leverage Novartis' target-specific assays to develop and test potential siRNAs. Once a lead candidate is identified, Novartis would spearhead further development and clinical research efforts.

Key companies within the biotechnology services market are dedicated to pioneering innovative therapies, such as biomarker algorithms for the primary treatment of patients with non-small cell lung cancer (NSCLC). Biomarker algorithms encompass mathematical or computational models integrating data from multiple biological indicators to provide comprehensive assessments of specific medical conditions. For instance, in April 2023, Strata Oncology Inc., a US-based precision oncology company, introduced Strata Select-a groundbreaking molecular profiling test for advanced cancer patients. Noteworthy for being the first immunotherapy biomarker algorithm covered by Medicare across solid tumors, Strata Select empowers oncologists to make more informed treatment decisions, thereby enhancing patient outcomes.

In October 2021, Amgen, a US-based biopharmaceutical company, completed the acquisition of Teneobio for $2.5 billion. The acquisition included Teneobio's bispecific and multispecific antibody technologies, enhancing Amgen's antibody expertise and BiTE platform. This strategic move aims to advance the discovery of novel molecules for treating various diseases within Amgen's key therapeutic areas. TeneoBio, the acquired company, is a US-based biotechnology firm known for its expertise in producing human heavy chain antibodies.

Major companies operating in the biotechnology services market report are Parexel International Corporation, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, IQVIA, ICON PLC, Charles River Laboratories, Syneos Health, Sartorius AG, Precision for Medicine Inc., Novartis, Eppendorf Asia Pacific Sdn. Bhd., Emmessar Biotech & Nutrition Ltd., Vcanbio Cell & Gene Engineering Corp., Ltd., Ke Rui Gene, Absea Biotechnology Ltd., CStone Pharm-B, Daiichi Sankyo, bitBiome, Taisho Pharmaceutical, AGC Biologics, Hamamatsu Pharma Research, Artios Pharma, AstraZeneca, Bio Products Laboratory (BPL), Cambridge Bioscience, Shire Pharmaceuticals Ltd., BTG Ltd., eXmoor Pharma, 4D Pharma PLC, Touchlight Genetics, Ophidia Medical Technologies, ATAI Life Sciences, Phaseform, Evotec, Sanity Group, Primmbiotech, , Vaccitech, Biolat, Pharmidea, Asla-Biotech, Genera, Anima Lab, Silvanols, OU TBD-Biodiscovery, Qvalitas Arstikeskus AS, Concise Systems OU, GPE Globalpharma OU, Belarusian National Biotechnology Corporation , Innothera , Olainfarm, Pharmaidea, Amgen Inc., Gilead Sciences, Celgene Corporation, Biogen Inc., Vertex Pharmaceuticals, Illumina, Inc., Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals , Hemostemix Inc., Resverlogix Corporation, Zenith Epigenetics Corp., Bayer, AMEGA Biotech, Pierre Fabre, Pfizer, Quantificare, Apsen Farmaceutica, BioMarin Pharmaceutical, DK Diagnostics, Biosonda Biotechnology, Laboratorios Legrand, Biomerics, Julphar Pharmaceuticals, Medpharma, Pharmax, Neopharma , City Breeze Technical Services, CinnaGen, BioSun Pharmed, AryoGen Pharmed, 4Clinics, 54gene, Amoun, Aspen Pharmacare, BBI Solutions, BioTech Africa, ClinArt MENA, Crux Pharmaceuticals, Genesis Pharmaceuticals, Massive Genomics, Mayne Pharma, Sanofi Genzyme, Teleflex Medical, The Micron Group

Asia-Pacific was the largest region in the biotechnology services market in 2023. North America was the second largest region in the global biotechnology services market analysis. The regions covered in the biotechnology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biotechnology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The biotechnology services market consists of revenue earned by entities that engage in conducting research and experimental development in biotechnology. Numerous global issues are helped by biotechnology, including infectious diseases, ageing societies, food security, energy security, and climate change, to name a few. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biotechnology Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biotechnology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biotechnology services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biotechnology services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Service: Prevention And Disease Control; Public Engagement Activities; Health Education And Research; Food Biotechnology Services; Donor Recruitment; Tissue Collection; Cell Processing And Isolation; Research And Development
  • 2) By Industry: Clinical Research Organizations (CROS); Contract Manufacturers Organizations (CMOS); And Contract Research And Manufacturing Services (CRAMS)
  • 3) By Area Of Application: Pharmaceutical; Biotechnology; Academic; Clinical Trial; Healthcare Sectors; Others
  • Companies Mentioned: Parexel International Corporation; Thermo Fisher Scientific; Laboratory Corporation of America Holdings; IQVIA; ICON plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biotechnology Services Market Characteristics

3. Biotechnology Services Market Trends And Strategies

4. Biotechnology Services Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biotechnology Services Market Size and Growth

  • 5.1. Global Biotechnology Services Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biotechnology Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biotechnology Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biotechnology Services Market Segmentation

  • 6.1. Global Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prevention and Disease Control
  • Public Engagement Activities
  • Health Education and Research
  • Food Biotechnology Services
  • Donor Recruitment
  • Tissue Collection
  • Cell Processing and Isolation
  • Research and Development
  • 6.2. Global Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinical Research Organizations (CROs)
  • Contract Manufacturers Organizations(CMOs)
  • Contract Research and Manufacturing Services (CRAMS)
  • 6.3. Global Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical
  • Biotechnological
  • Academic
  • Clinical Trial
  • Healthcare Sectors

7. Biotechnology Services Market Regional And Country Analysis

  • 7.1. Global Biotechnology Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biotechnology Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biotechnology Services Market

  • 8.1. Asia-Pacific Biotechnology Services Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biotechnology Services Market

  • 9.1. China Biotechnology Services Market Overview
  • 9.2. China Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biotechnology Services Market

  • 10.1. India Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biotechnology Services Market

  • 11.1. Japan Biotechnology Services Market Overview
  • 11.2. Japan Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biotechnology Services Market

  • 12.1. Australia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biotechnology Services Market

  • 13.1. Indonesia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biotechnology Services Market

  • 14.1. South Korea Biotechnology Services Market Overview
  • 14.2. South Korea Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biotechnology Services Market

  • 15.1. Western Europe Biotechnology Services Market Overview
  • 15.2. Western Europe Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biotechnology Services Market

  • 16.1. UK Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biotechnology Services Market

  • 17.1. Germany Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biotechnology Services Market

  • 18.1. France Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biotechnology Services Market

  • 19.1. Italy Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biotechnology Services Market

  • 20.1. Spain Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biotechnology Services Market

  • 21.1. Eastern Europe Biotechnology Services Market Overview
  • 21.2. Eastern Europe Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biotechnology Services Market

  • 22.1. Russia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biotechnology Services Market

  • 23.1. North America Biotechnology Services Market Overview
  • 23.2. North America Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biotechnology Services Market

  • 24.1. USA Biotechnology Services Market Overview
  • 24.2. USA Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biotechnology Services Market

  • 25.1. Canada Biotechnology Services Market Overview
  • 25.2. Canada Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biotechnology Services Market

  • 26.1. South America Biotechnology Services Market Overview
  • 26.2. South America Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biotechnology Services Market

  • 27.1. Brazil Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biotechnology Services Market

  • 28.1. Middle East Biotechnology Services Market Overview
  • 28.2. Middle East Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biotechnology Services Market

  • 29.1. Africa Biotechnology Services Market Overview
  • 29.2. Africa Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Biotechnology Services Market, Segmentation By Area of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biotechnology Services Market Competitive Landscape And Company Profiles

  • 30.1. Biotechnology Services Market Competitive Landscape
  • 30.2. Biotechnology Services Market Company Profiles
    • 30.2.1. Parexel International Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Laboratory Corporation of America Holdings
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. IQVIA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. ICON plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Biotechnology Services Market Other Major And Innovative Companies

  • 31.1. Charles River Laboratories
  • 31.2. Syneos Health
  • 31.3. Sartorius AG
  • 31.4. Precision for Medicine Inc.
  • 31.5. Novartis
  • 31.6. Eppendorf Asia Pacific Sdn. Bhd.
  • 31.7. Emmessar Biotech & Nutrition Ltd
  • 31.8. Vcanbio Cell & Gene Engineering Corp., Ltd
  • 31.9. Ke Rui Gene
  • 31.10. Absea Biotechnology Ltd
  • 31.11. CStone Pharm-B
  • 31.12. Daiichi Sankyo
  • 31.13. bitBiome
  • 31.14. Taisho Pharmaceutical
  • 31.15. AGC Biologics

32. Global Biotechnology Services Market Competitive Benchmarking

33. Global Biotechnology Services Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biotechnology Services Market

35. Biotechnology Services Market Future Outlook and Potential Analysis

  • 35.1 Biotechnology Services Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Biotechnology Services Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Biotechnology Services Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer